A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PPA / positive percent agreement

[Related PubMed/MEDLINE]
Total Number of Papers: 44
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PPA  (>> Co-occurring Abbreviation)
Long Form:   positive percent agreement
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects. NPA
2020 Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer. EGFR, NGS, NSCLC, PFS
2020 Performance of the ResistancePlus MG diagnostic test for Mycoplasma genitalium using samples collected with Hologic Aptima Specimen Collection kits. CI, MRM, NPA
2020 Validity, reliability, and psychometric properties of a computerized, cognitive assessment test (Cognivue). NPA
2019 A novel modality for intrapartum fetal heart rate monitoring. EMG, EUM, FHR
2019 Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients. AF, cfDNA, ctDNA, ddPCR, LOD, mCRC, NGS, NPA
2019 Assessment of readiness to transition from antenatal HIV surveillance surveys to PMTCT programme data-based HIV surveillance in South Africa: The 2017 Antenatal Sentinel HIV Survey. CI, IA, RT, WHO
2019 Development of a high throughput human stool specimen processing method for a molecular Helicobacter pylori clarithromycin resistance assay. H. pylori, qPCR
2019 Evaluation of a Novel High-Definition PCR Multiplex Assay for the Simultaneous Detection of Tick-Borne Pathogens in Human Clinical Specimens. LDTs, NPA, RUO, TBP
10  2019 Evaluation of the Aries Bordetella Assay for Detection and Identification of Bordetella pertussis in Nasopharyngeal Swab Specimens. Aries BA, CI, NPA, NPS, RP
11  2019 Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy. CGP, CRC, ctDNA, CUS, MSAF, NCCN, NPA, NPV, PPV
12  2019 High-volume workflow and performance comparisons for Chlamydia trachomatis and Neisseria gonorrhoeae testing using automated molecular platforms. CT, HoT, NG, NPA, OPA, STIs
13  2019 Multicenter Clinical Validation of the Molecular BD Max Enteric Viral Panel for Detection of Enteric Pathogens. Max EVP, NPA
14  2019 Performance of a Novel Fluorogenic Assay for Detection of Carbapenemase-Producing Enterobacteriaceae from Bacterial Colonies and Directly from Positive Blood Cultures. CIT, CNP, CPE, Fluore-C, Fluore-Direct, MALDI-TOF MS, mCIM, non-CP-CRE, RFU
15  2019 Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. EMA, FDA, NPA, OPA
16  2019 The use of cytological material in melanoma for programmed death ligand 1 immunostaining. CBs, IPOX, NPA, OA, PD-L1, TPS
17  2018 A 5-year study of the performance of the Verigene Gram-positive blood culture panel in a pediatric hospital. MRSA, MRSE, MSSA, MSSE, NPA, VRE
18  2018 Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu. CLIA, NP, NPA, RSV, RT-PCR
19  2018 Analytical validation of an ultra low-cost mobile phone microplate reader for infectious disease testing. CV, mHealth, mReader, NPA, OPA
20  2018 Comparative evaluation of the Omniplex-HPV and RFMP HPV PapilloTyper for detecting human papillomavirus genotypes in cervical specimens. HPV, NPA, OPA, RFMP
21  2018 Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens. hMPV, LRT, NP, NPA, Para 1 to 3, RSV, RV
22  2018 Evaluation of Senegal's prevention of mother to child transmission of HIV (PMTCT) program data for HIV surveillance. PMTCT, PNA, UAT
23  2018 Five-minute knee MRI for simultaneous morphometry and T2 relaxometry of cartilage and meniscus and for semiquantitative radiological assessment using double-echo in steady-state at 3T. CCI, CVs, DESS, MOAKS, NPA
24  2017 Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers. aMCI, HVs, IRA, IRR, NPA, pAD, PET, SUVRs
25  2017 Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US. CV, Ig, NPA, PT
26  2017 Evaluation of the Lumipulse G TP-N Chemiluminescent Immunoassay as a Syphilis Screening Test. CI, NPA, RPR, TPPA
27  2017 KRAS Mutation Test in Korean Patients with Colorectal Carcinomas: A Methodological Comparison between Sanger Sequencing and a Real-Time PCR-Based Assay. CRCs, NPA
28  2017 Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool Specimens. CI, ETEC, NPA, xEBP
29  2017 Rapid Identification of Five Classes of Carbapenem Resistance Genes Directly from Rectal Swabs by Use of the Xpert Carba-R Assay. CPO, NPA, qPCR
30  2017 Utilizing BD MAX™ Enteric Bacterial Panel to Detect Stool Pathogens from Rectal Swabs. BDM-EBP, EP, NPA, SBT
31  2016 Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686). CI, ORR
32  2016 Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. CI, EVD, NPA, qRT-PCR, ReEBOV RDT
33  2016 Multicenter Evaluation of the Xpert Norovirus Assay for Detection of Norovirus Genogroups I and II in Fecal Specimens. CDC, GI and GII, NPA, NPV, PPV
34  2015 Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis. NPA
35  2015 Evaluation of a new, rapid, simple test for the detection of influenza virus. NPA
36  2015 Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay. NPA
37  2015 Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes. EBP, EIAs, NPA
38  2015 Seizure detection with automated EEG analysis: a validation study focusing on periodic patterns. ASD, FPR, PLEDs
39  2014 Comparative evaluation of the new FDA approved THxID™-BRAF test with High Resolution Melting and Sanger sequencing. HRM, NPA
40  2014 Multi-center evaluation of the adenovirus R-gene US assay for the detection of adenovirus in respiratory samples. AdV, NPA
41  2013 Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas HPV Test results from the ATHENA study. Ct, hc2, HR-HPV, LA
42  2013 Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva. ELISAs, NPA, rSAG1
43  2013 Routine data from prevention of mother-to-child transmission (PMTCT) HIV testing not yet ready for HIV surveillance in Mozambique: a retrospective analysis of matched test results. ANC, CI, NPA, PMTCT
44  2011 The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. NPA